Log in or Sign up for Free to view tailored content for your specialty!
Oncology News
Time periods affected value of liver transplantation for patients with resectable HCC
The benefits of liver transplantation in patients with hepatocellular carcinoma were better than hepatic resection during a 10-year scenario compared with 5 years, according to an analysis evaluating both procedures in a recent study.
Surgical resection extended OS in huge hepatocellular carcinoma
Patients with huge hepatocellular carcinoma who underwent surgical resection demonstrated superior OS compared with patients who underwent transarterial chemoembolization, according to study results.
Log in or Sign up for Free to view tailored content for your specialty!
Surgical resection extended OS in huge hepatocellular carcinoma
Patients with huge hepatocellular carcinoma who underwent surgical resection demonstrated superior OS compared with patients who underwent transarterial chemoembolization, according to study results.
Sovaldi sales help push revenue increases for Gilead Sciences
Boosted by a 15% increase in 2013 antiviral product sales over the previous year, Gilead Sciences announced fourth-quarter sales were up 21% from 2012 and full-year revenues improved by 15%, according to a company press release.
WHO projects ‘alarming rise’ in cancer worldwide
Cancer will become a significantly larger global health care burden in the next 2 decades, with incidence expected to rise by 57% and deaths projected to increase by 63%, according to WHO’s World Cancer Report 2014.
Patients with Child-Turcotte-Pugh class A liver function showed better OS among those with advanced HCC
Patients with advanced hepatocellular carcinoma who failed first-line therapy may have benefited from having liver reserves of Child-Turcotte-Pugh class A or being eligible for clinical trials to improve their prognosis for overall survival, according to study data.
Monitoring inactive chronic HBV carriers appears cost-effective
Recent study data have found that lifelong monitoring of individuals carrying dormant chronic hepatitis B in Shanghai appears to be cost-effective, but meaningful effects on hepatocellular carcinoma, cirrhosis and chronic hepatitis B mortality would require increased testing, follow-up and treatment rates of active patients.
Surgeon General report identifies more health hazards from smoking
Diabetes, colorectal and liver cancer, rheumatoid arthritis, erectile dysfunction, age-related macular degeneration and other conditions have now been added to the list of diseases caused by cigarette smoking or exposure to secondhand smoke, according to a new report issued by the Surgeon General of the United States.
Surgeon General report identifies more health hazards from smoking
Diabetes, colorectal and liver cancer, rheumatoid arthritis, erectile dysfunction, age-related macular degeneration and other conditions have now been added to the list of diseases caused by cigarette smoking or exposure to secondhand smoke, according to a new report issued by the Surgeon General of the United States.
Method detected HCC nodules earlier, did not improve survival
Despite success in detecting hepatocellular carcinoma nodules that conventional dynamic computed tomography failed to reveal, combined computed tomography with hepatic arteriography and arterial portography did not result in improved cumulative recurrence-free survival or overall survival, a recent study found.
-
Headline News
NIH finds neuroscience director engaged in research misconduct
September 26, 20241 min read -
Headline News
Q&A: Phone app uses AI technology to personalize allergy forecasts
September 25, 20243 min read -
Headline News
FDA grants fast track designation to brepocitinib for noninfectious uveitis
September 25, 20241 min read
-
Headline News
NIH finds neuroscience director engaged in research misconduct
September 26, 20241 min read -
Headline News
Q&A: Phone app uses AI technology to personalize allergy forecasts
September 25, 20243 min read -
Headline News
FDA grants fast track designation to brepocitinib for noninfectious uveitis
September 25, 20241 min read